ArticlemedRxiv : the preprint server for health sciences2025

AAV9 Gene Therapy in GM1 Gangliosidosis Type II: A Phase 1/2 Trial.

Connor J Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.